Global AI in Respiratory Diseases Market Growth (Status and Outlook) 2026-2032
The global AI in Respiratory Diseases market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
United States market for AI in Respiratory Diseases is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for AI in Respiratory Diseases is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for AI in Respiratory Diseases is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key AI in Respiratory Diseases players cover ArtiQ, Philips Healthcare, GE Healthcare, Siemens Healthineers, Swaasa AI, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?AI in Respiratory Diseases Industry Forecast? looks at past sales and reviews total world AI in Respiratory Diseases sales in 2025, providing a comprehensive analysis by region and market sector of projected AI in Respiratory Diseases sales for 2026 through 2032. With AI in Respiratory Diseases sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world AI in Respiratory Diseases industry.
This Insight Report provides a comprehensive analysis of the global AI in Respiratory Diseases landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on AI in Respiratory Diseases portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global AI in Respiratory Diseases market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AI in Respiratory Diseases and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AI in Respiratory Diseases.
This report presents a comprehensive overview, market shares, and growth opportunities of AI in Respiratory Diseases market by product type, application, key players and key regions and countries.
Segmentation by Type:
United States market for AI in Respiratory Diseases is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for AI in Respiratory Diseases is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for AI in Respiratory Diseases is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key AI in Respiratory Diseases players cover ArtiQ, Philips Healthcare, GE Healthcare, Siemens Healthineers, Swaasa AI, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?AI in Respiratory Diseases Industry Forecast? looks at past sales and reviews total world AI in Respiratory Diseases sales in 2025, providing a comprehensive analysis by region and market sector of projected AI in Respiratory Diseases sales for 2026 through 2032. With AI in Respiratory Diseases sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world AI in Respiratory Diseases industry.
This Insight Report provides a comprehensive analysis of the global AI in Respiratory Diseases landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on AI in Respiratory Diseases portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global AI in Respiratory Diseases market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AI in Respiratory Diseases and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AI in Respiratory Diseases.
This report presents a comprehensive overview, market shares, and growth opportunities of AI in Respiratory Diseases market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Pulmonary Infection
- MRI
- CT Scan
- Hospital
- Diagnostic Centers
- Ambulatory Surgical Centers
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- ArtiQ
- Philips Healthcare
- GE Healthcare
- Siemens Healthineers
- Swaasa AI
- THIRONA
- DeepMind Health
- Verily
- VIDA Diagnostics Inc
- Icometrix
- Infervision
- PneumoWave
- Respiray
- Dectrocel Healthcare
- Zynnon
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global AI in Respiratory Diseases Market Size (2021-2032)
2.1.2 AI in Respiratory Diseases Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for AI in Respiratory Diseases by Country/Region (2021, 2025 & 2032)
2.2 AI in Respiratory Diseases Segment by Type
2.2.1 Pulmonary Infection
2.2.2 MRI
2.2.3 CT Scan
2.2.4 AI in Respiratory Diseases Market Size by Type
2.2.4.1 AI in Respiratory Diseases Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global AI in Respiratory Diseases Market Size Market Share by Type (2021-2026)
2.3 AI in Respiratory Diseases Segment by Application
2.3.1 Hospital
2.3.2 Diagnostic Centers
2.3.3 Ambulatory Surgical Centers
2.3.4 Others
2.3.5 AI in Respiratory Diseases Market Size by Application
2.3.5.1 AI in Respiratory Diseases Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.5.2 Global AI in Respiratory Diseases Market Size Market Share by Application (2021-2026)
3 AI IN RESPIRATORY DISEASES MARKET SIZE BY PLAYER
3.1 AI in Respiratory Diseases Market Size Market Share by Player
3.1.1 Global AI in Respiratory Diseases Revenue by Player (2021-2026)
3.1.2 Global AI in Respiratory Diseases Revenue Market Share by Player (2021-2026)
3.2 Global AI in Respiratory Diseases Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AI IN RESPIRATORY DISEASES BY REGION
4.1 AI in Respiratory Diseases Market Size by Region (2021-2026)
4.2 Global AI in Respiratory Diseases Annual Revenue by Country/Region (2021-2026)
4.3 Americas AI in Respiratory Diseases Market Size Growth (2021-2026)
4.4 APAC AI in Respiratory Diseases Market Size Growth (2021-2026)
4.5 Europe AI in Respiratory Diseases Market Size Growth (2021-2026)
4.6 Middle East & Africa AI in Respiratory Diseases Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas AI in Respiratory Diseases Market Size by Country (2021-2026)
5.2 Americas AI in Respiratory Diseases Market Size by Type (2021-2026)
5.3 Americas AI in Respiratory Diseases Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC AI in Respiratory Diseases Market Size by Region (2021-2026)
6.2 APAC AI in Respiratory Diseases Market Size by Type (2021-2026)
6.3 APAC AI in Respiratory Diseases Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe AI in Respiratory Diseases Market Size by Country (2021-2026)
7.2 Europe AI in Respiratory Diseases Market Size by Type (2021-2026)
7.3 Europe AI in Respiratory Diseases Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa AI in Respiratory Diseases by Region (2021-2026)
8.2 Middle East & Africa AI in Respiratory Diseases Market Size by Type (2021-2026)
8.3 Middle East & Africa AI in Respiratory Diseases Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL AI IN RESPIRATORY DISEASES MARKET FORECAST
10.1 Global AI in Respiratory Diseases Forecast by Region (2027-2032)
10.1.1 Global AI in Respiratory Diseases Forecast by Region (2027-2032)
10.1.2 Americas AI in Respiratory Diseases Forecast
10.1.3 APAC AI in Respiratory Diseases Forecast
10.1.4 Europe AI in Respiratory Diseases Forecast
10.1.5 Middle East & Africa AI in Respiratory Diseases Forecast
10.2 Americas AI in Respiratory Diseases Forecast by Country (2027-2032)
10.2.1 United States Market AI in Respiratory Diseases Forecast
10.2.2 Canada Market AI in Respiratory Diseases Forecast
10.2.3 Mexico Market AI in Respiratory Diseases Forecast
10.2.4 Brazil Market AI in Respiratory Diseases Forecast
10.3 APAC AI in Respiratory Diseases Forecast by Region (2027-2032)
10.3.1 China AI in Respiratory Diseases Market Forecast
10.3.2 Japan Market AI in Respiratory Diseases Forecast
10.3.3 Korea Market AI in Respiratory Diseases Forecast
10.3.4 Southeast Asia Market AI in Respiratory Diseases Forecast
10.3.5 India Market AI in Respiratory Diseases Forecast
10.3.6 Australia Market AI in Respiratory Diseases Forecast
10.4 Europe AI in Respiratory Diseases Forecast by Country (2027-2032)
10.4.1 Germany Market AI in Respiratory Diseases Forecast
10.4.2 France Market AI in Respiratory Diseases Forecast
10.4.3 UK Market AI in Respiratory Diseases Forecast
10.4.4 Italy Market AI in Respiratory Diseases Forecast
10.4.5 Russia Market AI in Respiratory Diseases Forecast
10.5 Middle East & Africa AI in Respiratory Diseases Forecast by Region (2027-2032)
10.5.1 Egypt Market AI in Respiratory Diseases Forecast
10.5.2 South Africa Market AI in Respiratory Diseases Forecast
10.5.3 Israel Market AI in Respiratory Diseases Forecast
10.5.4 Turkey Market AI in Respiratory Diseases Forecast
10.6 Global AI in Respiratory Diseases Forecast by Type (2027-2032)
10.7 Global AI in Respiratory Diseases Forecast by Application (2027-2032)
10.7.1 GCC Countries Market AI in Respiratory Diseases Forecast
11 KEY PLAYERS ANALYSIS
11.1 ArtiQ
11.1.1 ArtiQ Company Information
11.1.2 ArtiQ AI in Respiratory Diseases Product Offered
11.1.3 ArtiQ AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 ArtiQ Main Business Overview
11.1.5 ArtiQ Latest Developments
11.2 Philips Healthcare
11.2.1 Philips Healthcare Company Information
11.2.2 Philips Healthcare AI in Respiratory Diseases Product Offered
11.2.3 Philips Healthcare AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Philips Healthcare Main Business Overview
11.2.5 Philips Healthcare Latest Developments
11.3 GE Healthcare
11.3.1 GE Healthcare Company Information
11.3.2 GE Healthcare AI in Respiratory Diseases Product Offered
11.3.3 GE Healthcare AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 GE Healthcare Main Business Overview
11.3.5 GE Healthcare Latest Developments
11.4 Siemens Healthineers
11.4.1 Siemens Healthineers Company Information
11.4.2 Siemens Healthineers AI in Respiratory Diseases Product Offered
11.4.3 Siemens Healthineers AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Siemens Healthineers Main Business Overview
11.4.5 Siemens Healthineers Latest Developments
11.5 Swaasa AI
11.5.1 Swaasa AI Company Information
11.5.2 Swaasa AI AI in Respiratory Diseases Product Offered
11.5.3 Swaasa AI AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Swaasa AI Main Business Overview
11.5.5 Swaasa AI Latest Developments
11.6 THIRONA
11.6.1 THIRONA Company Information
11.6.2 THIRONA AI in Respiratory Diseases Product Offered
11.6.3 THIRONA AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 THIRONA Main Business Overview
11.6.5 THIRONA Latest Developments
11.7 DeepMind Health
11.7.1 DeepMind Health Company Information
11.7.2 DeepMind Health AI in Respiratory Diseases Product Offered
11.7.3 DeepMind Health AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 DeepMind Health Main Business Overview
11.7.5 DeepMind Health Latest Developments
11.8 Verily
11.8.1 Verily Company Information
11.8.2 Verily AI in Respiratory Diseases Product Offered
11.8.3 Verily AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Verily Main Business Overview
11.8.5 Verily Latest Developments
11.9 VIDA Diagnostics Inc
11.9.1 VIDA Diagnostics Inc Company Information
11.9.2 VIDA Diagnostics Inc AI in Respiratory Diseases Product Offered
11.9.3 VIDA Diagnostics Inc AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 VIDA Diagnostics Inc Main Business Overview
11.9.5 VIDA Diagnostics Inc Latest Developments
11.10 Icometrix
11.10.1 Icometrix Company Information
11.10.2 Icometrix AI in Respiratory Diseases Product Offered
11.10.3 Icometrix AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Icometrix Main Business Overview
11.10.5 Icometrix Latest Developments
11.11 Infervision
11.11.1 Infervision Company Information
11.11.2 Infervision AI in Respiratory Diseases Product Offered
11.11.3 Infervision AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Infervision Main Business Overview
11.11.5 Infervision Latest Developments
11.12 PneumoWave
11.12.1 PneumoWave Company Information
11.12.2 PneumoWave AI in Respiratory Diseases Product Offered
11.12.3 PneumoWave AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 PneumoWave Main Business Overview
11.12.5 PneumoWave Latest Developments
11.13 Respiray
11.13.1 Respiray Company Information
11.13.2 Respiray AI in Respiratory Diseases Product Offered
11.13.3 Respiray AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Respiray Main Business Overview
11.13.5 Respiray Latest Developments
11.14 Dectrocel Healthcare
11.14.1 Dectrocel Healthcare Company Information
11.14.2 Dectrocel Healthcare AI in Respiratory Diseases Product Offered
11.14.3 Dectrocel Healthcare AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Dectrocel Healthcare Main Business Overview
11.14.5 Dectrocel Healthcare Latest Developments
11.15 Zynnon
11.15.1 Zynnon Company Information
11.15.2 Zynnon AI in Respiratory Diseases Product Offered
11.15.3 Zynnon AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Zynnon Main Business Overview
11.15.5 Zynnon Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global AI in Respiratory Diseases Market Size (2021-2032)
2.1.2 AI in Respiratory Diseases Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for AI in Respiratory Diseases by Country/Region (2021, 2025 & 2032)
2.2 AI in Respiratory Diseases Segment by Type
2.2.1 Pulmonary Infection
2.2.2 MRI
2.2.3 CT Scan
2.2.4 AI in Respiratory Diseases Market Size by Type
2.2.4.1 AI in Respiratory Diseases Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global AI in Respiratory Diseases Market Size Market Share by Type (2021-2026)
2.3 AI in Respiratory Diseases Segment by Application
2.3.1 Hospital
2.3.2 Diagnostic Centers
2.3.3 Ambulatory Surgical Centers
2.3.4 Others
2.3.5 AI in Respiratory Diseases Market Size by Application
2.3.5.1 AI in Respiratory Diseases Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.5.2 Global AI in Respiratory Diseases Market Size Market Share by Application (2021-2026)
3 AI IN RESPIRATORY DISEASES MARKET SIZE BY PLAYER
3.1 AI in Respiratory Diseases Market Size Market Share by Player
3.1.1 Global AI in Respiratory Diseases Revenue by Player (2021-2026)
3.1.2 Global AI in Respiratory Diseases Revenue Market Share by Player (2021-2026)
3.2 Global AI in Respiratory Diseases Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AI IN RESPIRATORY DISEASES BY REGION
4.1 AI in Respiratory Diseases Market Size by Region (2021-2026)
4.2 Global AI in Respiratory Diseases Annual Revenue by Country/Region (2021-2026)
4.3 Americas AI in Respiratory Diseases Market Size Growth (2021-2026)
4.4 APAC AI in Respiratory Diseases Market Size Growth (2021-2026)
4.5 Europe AI in Respiratory Diseases Market Size Growth (2021-2026)
4.6 Middle East & Africa AI in Respiratory Diseases Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas AI in Respiratory Diseases Market Size by Country (2021-2026)
5.2 Americas AI in Respiratory Diseases Market Size by Type (2021-2026)
5.3 Americas AI in Respiratory Diseases Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC AI in Respiratory Diseases Market Size by Region (2021-2026)
6.2 APAC AI in Respiratory Diseases Market Size by Type (2021-2026)
6.3 APAC AI in Respiratory Diseases Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe AI in Respiratory Diseases Market Size by Country (2021-2026)
7.2 Europe AI in Respiratory Diseases Market Size by Type (2021-2026)
7.3 Europe AI in Respiratory Diseases Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa AI in Respiratory Diseases by Region (2021-2026)
8.2 Middle East & Africa AI in Respiratory Diseases Market Size by Type (2021-2026)
8.3 Middle East & Africa AI in Respiratory Diseases Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL AI IN RESPIRATORY DISEASES MARKET FORECAST
10.1 Global AI in Respiratory Diseases Forecast by Region (2027-2032)
10.1.1 Global AI in Respiratory Diseases Forecast by Region (2027-2032)
10.1.2 Americas AI in Respiratory Diseases Forecast
10.1.3 APAC AI in Respiratory Diseases Forecast
10.1.4 Europe AI in Respiratory Diseases Forecast
10.1.5 Middle East & Africa AI in Respiratory Diseases Forecast
10.2 Americas AI in Respiratory Diseases Forecast by Country (2027-2032)
10.2.1 United States Market AI in Respiratory Diseases Forecast
10.2.2 Canada Market AI in Respiratory Diseases Forecast
10.2.3 Mexico Market AI in Respiratory Diseases Forecast
10.2.4 Brazil Market AI in Respiratory Diseases Forecast
10.3 APAC AI in Respiratory Diseases Forecast by Region (2027-2032)
10.3.1 China AI in Respiratory Diseases Market Forecast
10.3.2 Japan Market AI in Respiratory Diseases Forecast
10.3.3 Korea Market AI in Respiratory Diseases Forecast
10.3.4 Southeast Asia Market AI in Respiratory Diseases Forecast
10.3.5 India Market AI in Respiratory Diseases Forecast
10.3.6 Australia Market AI in Respiratory Diseases Forecast
10.4 Europe AI in Respiratory Diseases Forecast by Country (2027-2032)
10.4.1 Germany Market AI in Respiratory Diseases Forecast
10.4.2 France Market AI in Respiratory Diseases Forecast
10.4.3 UK Market AI in Respiratory Diseases Forecast
10.4.4 Italy Market AI in Respiratory Diseases Forecast
10.4.5 Russia Market AI in Respiratory Diseases Forecast
10.5 Middle East & Africa AI in Respiratory Diseases Forecast by Region (2027-2032)
10.5.1 Egypt Market AI in Respiratory Diseases Forecast
10.5.2 South Africa Market AI in Respiratory Diseases Forecast
10.5.3 Israel Market AI in Respiratory Diseases Forecast
10.5.4 Turkey Market AI in Respiratory Diseases Forecast
10.6 Global AI in Respiratory Diseases Forecast by Type (2027-2032)
10.7 Global AI in Respiratory Diseases Forecast by Application (2027-2032)
10.7.1 GCC Countries Market AI in Respiratory Diseases Forecast
11 KEY PLAYERS ANALYSIS
11.1 ArtiQ
11.1.1 ArtiQ Company Information
11.1.2 ArtiQ AI in Respiratory Diseases Product Offered
11.1.3 ArtiQ AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 ArtiQ Main Business Overview
11.1.5 ArtiQ Latest Developments
11.2 Philips Healthcare
11.2.1 Philips Healthcare Company Information
11.2.2 Philips Healthcare AI in Respiratory Diseases Product Offered
11.2.3 Philips Healthcare AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Philips Healthcare Main Business Overview
11.2.5 Philips Healthcare Latest Developments
11.3 GE Healthcare
11.3.1 GE Healthcare Company Information
11.3.2 GE Healthcare AI in Respiratory Diseases Product Offered
11.3.3 GE Healthcare AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 GE Healthcare Main Business Overview
11.3.5 GE Healthcare Latest Developments
11.4 Siemens Healthineers
11.4.1 Siemens Healthineers Company Information
11.4.2 Siemens Healthineers AI in Respiratory Diseases Product Offered
11.4.3 Siemens Healthineers AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Siemens Healthineers Main Business Overview
11.4.5 Siemens Healthineers Latest Developments
11.5 Swaasa AI
11.5.1 Swaasa AI Company Information
11.5.2 Swaasa AI AI in Respiratory Diseases Product Offered
11.5.3 Swaasa AI AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Swaasa AI Main Business Overview
11.5.5 Swaasa AI Latest Developments
11.6 THIRONA
11.6.1 THIRONA Company Information
11.6.2 THIRONA AI in Respiratory Diseases Product Offered
11.6.3 THIRONA AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 THIRONA Main Business Overview
11.6.5 THIRONA Latest Developments
11.7 DeepMind Health
11.7.1 DeepMind Health Company Information
11.7.2 DeepMind Health AI in Respiratory Diseases Product Offered
11.7.3 DeepMind Health AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 DeepMind Health Main Business Overview
11.7.5 DeepMind Health Latest Developments
11.8 Verily
11.8.1 Verily Company Information
11.8.2 Verily AI in Respiratory Diseases Product Offered
11.8.3 Verily AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Verily Main Business Overview
11.8.5 Verily Latest Developments
11.9 VIDA Diagnostics Inc
11.9.1 VIDA Diagnostics Inc Company Information
11.9.2 VIDA Diagnostics Inc AI in Respiratory Diseases Product Offered
11.9.3 VIDA Diagnostics Inc AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 VIDA Diagnostics Inc Main Business Overview
11.9.5 VIDA Diagnostics Inc Latest Developments
11.10 Icometrix
11.10.1 Icometrix Company Information
11.10.2 Icometrix AI in Respiratory Diseases Product Offered
11.10.3 Icometrix AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Icometrix Main Business Overview
11.10.5 Icometrix Latest Developments
11.11 Infervision
11.11.1 Infervision Company Information
11.11.2 Infervision AI in Respiratory Diseases Product Offered
11.11.3 Infervision AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Infervision Main Business Overview
11.11.5 Infervision Latest Developments
11.12 PneumoWave
11.12.1 PneumoWave Company Information
11.12.2 PneumoWave AI in Respiratory Diseases Product Offered
11.12.3 PneumoWave AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 PneumoWave Main Business Overview
11.12.5 PneumoWave Latest Developments
11.13 Respiray
11.13.1 Respiray Company Information
11.13.2 Respiray AI in Respiratory Diseases Product Offered
11.13.3 Respiray AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Respiray Main Business Overview
11.13.5 Respiray Latest Developments
11.14 Dectrocel Healthcare
11.14.1 Dectrocel Healthcare Company Information
11.14.2 Dectrocel Healthcare AI in Respiratory Diseases Product Offered
11.14.3 Dectrocel Healthcare AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Dectrocel Healthcare Main Business Overview
11.14.5 Dectrocel Healthcare Latest Developments
11.15 Zynnon
11.15.1 Zynnon Company Information
11.15.2 Zynnon AI in Respiratory Diseases Product Offered
11.15.3 Zynnon AI in Respiratory Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Zynnon Main Business Overview
11.15.5 Zynnon Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. AI in Respiratory Diseases Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. AI in Respiratory Diseases Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Pulmonary Infection
Table 4. Major Players of MRI
Table 5. Major Players of CT Scan
Table 6. AI in Respiratory Diseases Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global AI in Respiratory Diseases Market Size by Type (2021-2026) & ($ millions)
Table 8. Global AI in Respiratory Diseases Market Size Market Share by Type (2021-2026)
Table 9. AI in Respiratory Diseases Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global AI in Respiratory Diseases Market Size by Application (2021-2026) & ($ millions)
Table 11. Global AI in Respiratory Diseases Market Size Market Share by Application (2021-2026)
Table 12. Global AI in Respiratory Diseases Revenue by Player (2021-2026) & ($ millions)
Table 13. Global AI in Respiratory Diseases Revenue Market Share by Player (2021-2026)
Table 14. AI in Respiratory Diseases Key Players Head office and Products Offered
Table 15. AI in Respiratory Diseases Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global AI in Respiratory Diseases Market Size by Region (2021-2026) & ($ millions)
Table 19. Global AI in Respiratory Diseases Market Size Market Share by Region (2021-2026)
Table 20. Global AI in Respiratory Diseases Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global AI in Respiratory Diseases Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas AI in Respiratory Diseases Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas AI in Respiratory Diseases Market Size Market Share by Country (2021-2026)
Table 24. Americas AI in Respiratory Diseases Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas AI in Respiratory Diseases Market Size Market Share by Type (2021-2026)
Table 26. Americas AI in Respiratory Diseases Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas AI in Respiratory Diseases Market Size Market Share by Application (2021-2026)
Table 28. APAC AI in Respiratory Diseases Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC AI in Respiratory Diseases Market Size Market Share by Region (2021-2026)
Table 30. APAC AI in Respiratory Diseases Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC AI in Respiratory Diseases Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe AI in Respiratory Diseases Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe AI in Respiratory Diseases Market Size Market Share by Country (2021-2026)
Table 34. Europe AI in Respiratory Diseases Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe AI in Respiratory Diseases Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa AI in Respiratory Diseases Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa AI in Respiratory Diseases Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa AI in Respiratory Diseases Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of AI in Respiratory Diseases
Table 40. Key Market Challenges & Risks of AI in Respiratory Diseases
Table 41. Key Industry Trends of AI in Respiratory Diseases
Table 42. Global AI in Respiratory Diseases Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global AI in Respiratory Diseases Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global AI in Respiratory Diseases Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global AI in Respiratory Diseases Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. ArtiQ Details, Company Type, AI in Respiratory Diseases Area Served and Its Competitors
Table 47. ArtiQ AI in Respiratory Diseases Product Offered
Table 48. ArtiQ AI in Respiratory Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. ArtiQ Main Business
Table 50. ArtiQ Latest Developments
Table 51. Philips Healthcare Details, Company Type, AI in Respiratory Diseases Area Served and Its Competitors
Table 52. Philips Healthcare AI in Respiratory Diseases Product Offered
Table 53. Philips Healthcare AI in Respiratory Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Philips Healthcare Main Business
Table 55. Philips Healthcare Latest Developments
Table 56. GE Healthcare Details, Company Type, AI in Respiratory Diseases Area Served and Its Competitors
Table 57. GE Healthcare AI in Respiratory Diseases Product Offered
Table 58. GE Healthcare AI in Respiratory Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. GE Healthcare Main Business
Table 60. GE Healthcare Latest Developments
Table 61. Siemens Healthineers Details, Company Type, AI in Respiratory Diseases Area Served and Its Competitors
Table 62. Siemens Healthineers AI in Respiratory Diseases Product Offered
Table 63. Siemens Healthineers AI in Respiratory Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Siemens Healthineers Main Business
Table 65. Siemens Healthineers Latest Developments
Table 66. Swaasa AI Details, Company Type, AI in Respiratory Diseases Area Served and Its Competitors
Table 67. Swaasa AI AI in Respiratory Diseases Product Offered
Table 68. Swaasa AI AI in Respiratory Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Swaasa AI Main Business
Table 70. Swaasa AI Latest Developments
Table 71. THIRONA Details, Company Type, AI in Respiratory Diseases Area Served and Its Competitors
Table 72. THIRONA AI in Respiratory Diseases Product Offered
Table 73. THIRONA AI in Respiratory Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. THIRONA Main Business
Table 75. THIRONA Latest Developments
Table 76. DeepMind Health Details, Company Type, AI in Respiratory Diseases Area Served and Its Competitors
Table 77. DeepMind Health AI in Respiratory Diseases Product Offered
Table 78. DeepMind Health AI in Respiratory Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. DeepMind Health Main Business
Table 80. DeepMind Health Latest Developments
Table 81. Verily Details, Company Type, AI in Respiratory Diseases Area Served and Its Competitors
Table 82. Verily AI in Respiratory Diseases Product Offered
Table 83. Verily AI in Respiratory Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Verily Main Business
Table 85. Verily Latest Developments
Table 86. VIDA Diagnostics Inc Details, Company Type, AI in Respiratory Diseases Area Served and Its Competitors
Table 87. VIDA Diagnostics Inc AI in Respiratory Diseases Product Offered
Table 88. VIDA Diagnostics Inc AI in Respiratory Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. VIDA Diagnostics Inc Main Business
Table 90. VIDA Diagnostics Inc Latest Developments
Table 91. Icometrix Details, Company Type, AI in Respiratory Diseases Area Served and Its Competitors
Table 92. Icometrix AI in Respiratory Diseases Product Offered
Table 93. Icometrix AI in Respiratory Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Icometrix Main Business
Table 95. Icometrix Latest Developments
Table 96. Infervision Details, Company Type, AI in Respiratory Diseases Area Served and Its Competitors
Table 97. Infervision AI in Respiratory Diseases Product Offered
Table 98. Infervision AI in Respiratory Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Infervision Main Business
Table 100. Infervision Latest Developments
Table 101. PneumoWave Details, Company Type, AI in Respiratory Diseases Area Served and Its Competitors
Table 102. PneumoWave AI in Respiratory Diseases Product Offered
Table 103. PneumoWave AI in Respiratory Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. PneumoWave Main Business
Table 105. PneumoWave Latest Developments
Table 106. Respiray Details, Company Type, AI in Respiratory Diseases Area Served and Its Competitors
Table 107. Respiray AI in Respiratory Diseases Product Offered
Table 108. Respiray AI in Respiratory Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Respiray Main Business
Table 110. Respiray Latest Developments
Table 111. Dectrocel Healthcare Details, Company Type, AI in Respiratory Diseases Area Served and Its Competitors
Table 112. Dectrocel Healthcare AI in Respiratory Diseases Product Offered
Table 113. Dectrocel Healthcare AI in Respiratory Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Dectrocel Healthcare Main Business
Table 115. Dectrocel Healthcare Latest Developments
Table 116. Zynnon Details, Company Type, AI in Respiratory Diseases Area Served and Its Competitors
Table 117. Zynnon AI in Respiratory Diseases Product Offered
Table 118. Zynnon AI in Respiratory Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. Zynnon Main Business
Table 120. Zynnon Latest Developments
Table 1. AI in Respiratory Diseases Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. AI in Respiratory Diseases Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Pulmonary Infection
Table 4. Major Players of MRI
Table 5. Major Players of CT Scan
Table 6. AI in Respiratory Diseases Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global AI in Respiratory Diseases Market Size by Type (2021-2026) & ($ millions)
Table 8. Global AI in Respiratory Diseases Market Size Market Share by Type (2021-2026)
Table 9. AI in Respiratory Diseases Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global AI in Respiratory Diseases Market Size by Application (2021-2026) & ($ millions)
Table 11. Global AI in Respiratory Diseases Market Size Market Share by Application (2021-2026)
Table 12. Global AI in Respiratory Diseases Revenue by Player (2021-2026) & ($ millions)
Table 13. Global AI in Respiratory Diseases Revenue Market Share by Player (2021-2026)
Table 14. AI in Respiratory Diseases Key Players Head office and Products Offered
Table 15. AI in Respiratory Diseases Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global AI in Respiratory Diseases Market Size by Region (2021-2026) & ($ millions)
Table 19. Global AI in Respiratory Diseases Market Size Market Share by Region (2021-2026)
Table 20. Global AI in Respiratory Diseases Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global AI in Respiratory Diseases Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas AI in Respiratory Diseases Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas AI in Respiratory Diseases Market Size Market Share by Country (2021-2026)
Table 24. Americas AI in Respiratory Diseases Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas AI in Respiratory Diseases Market Size Market Share by Type (2021-2026)
Table 26. Americas AI in Respiratory Diseases Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas AI in Respiratory Diseases Market Size Market Share by Application (2021-2026)
Table 28. APAC AI in Respiratory Diseases Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC AI in Respiratory Diseases Market Size Market Share by Region (2021-2026)
Table 30. APAC AI in Respiratory Diseases Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC AI in Respiratory Diseases Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe AI in Respiratory Diseases Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe AI in Respiratory Diseases Market Size Market Share by Country (2021-2026)
Table 34. Europe AI in Respiratory Diseases Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe AI in Respiratory Diseases Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa AI in Respiratory Diseases Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa AI in Respiratory Diseases Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa AI in Respiratory Diseases Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of AI in Respiratory Diseases
Table 40. Key Market Challenges & Risks of AI in Respiratory Diseases
Table 41. Key Industry Trends of AI in Respiratory Diseases
Table 42. Global AI in Respiratory Diseases Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global AI in Respiratory Diseases Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global AI in Respiratory Diseases Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global AI in Respiratory Diseases Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. ArtiQ Details, Company Type, AI in Respiratory Diseases Area Served and Its Competitors
Table 47. ArtiQ AI in Respiratory Diseases Product Offered
Table 48. ArtiQ AI in Respiratory Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. ArtiQ Main Business
Table 50. ArtiQ Latest Developments
Table 51. Philips Healthcare Details, Company Type, AI in Respiratory Diseases Area Served and Its Competitors
Table 52. Philips Healthcare AI in Respiratory Diseases Product Offered
Table 53. Philips Healthcare AI in Respiratory Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Philips Healthcare Main Business
Table 55. Philips Healthcare Latest Developments
Table 56. GE Healthcare Details, Company Type, AI in Respiratory Diseases Area Served and Its Competitors
Table 57. GE Healthcare AI in Respiratory Diseases Product Offered
Table 58. GE Healthcare AI in Respiratory Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. GE Healthcare Main Business
Table 60. GE Healthcare Latest Developments
Table 61. Siemens Healthineers Details, Company Type, AI in Respiratory Diseases Area Served and Its Competitors
Table 62. Siemens Healthineers AI in Respiratory Diseases Product Offered
Table 63. Siemens Healthineers AI in Respiratory Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Siemens Healthineers Main Business
Table 65. Siemens Healthineers Latest Developments
Table 66. Swaasa AI Details, Company Type, AI in Respiratory Diseases Area Served and Its Competitors
Table 67. Swaasa AI AI in Respiratory Diseases Product Offered
Table 68. Swaasa AI AI in Respiratory Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Swaasa AI Main Business
Table 70. Swaasa AI Latest Developments
Table 71. THIRONA Details, Company Type, AI in Respiratory Diseases Area Served and Its Competitors
Table 72. THIRONA AI in Respiratory Diseases Product Offered
Table 73. THIRONA AI in Respiratory Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. THIRONA Main Business
Table 75. THIRONA Latest Developments
Table 76. DeepMind Health Details, Company Type, AI in Respiratory Diseases Area Served and Its Competitors
Table 77. DeepMind Health AI in Respiratory Diseases Product Offered
Table 78. DeepMind Health AI in Respiratory Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. DeepMind Health Main Business
Table 80. DeepMind Health Latest Developments
Table 81. Verily Details, Company Type, AI in Respiratory Diseases Area Served and Its Competitors
Table 82. Verily AI in Respiratory Diseases Product Offered
Table 83. Verily AI in Respiratory Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Verily Main Business
Table 85. Verily Latest Developments
Table 86. VIDA Diagnostics Inc Details, Company Type, AI in Respiratory Diseases Area Served and Its Competitors
Table 87. VIDA Diagnostics Inc AI in Respiratory Diseases Product Offered
Table 88. VIDA Diagnostics Inc AI in Respiratory Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. VIDA Diagnostics Inc Main Business
Table 90. VIDA Diagnostics Inc Latest Developments
Table 91. Icometrix Details, Company Type, AI in Respiratory Diseases Area Served and Its Competitors
Table 92. Icometrix AI in Respiratory Diseases Product Offered
Table 93. Icometrix AI in Respiratory Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Icometrix Main Business
Table 95. Icometrix Latest Developments
Table 96. Infervision Details, Company Type, AI in Respiratory Diseases Area Served and Its Competitors
Table 97. Infervision AI in Respiratory Diseases Product Offered
Table 98. Infervision AI in Respiratory Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Infervision Main Business
Table 100. Infervision Latest Developments
Table 101. PneumoWave Details, Company Type, AI in Respiratory Diseases Area Served and Its Competitors
Table 102. PneumoWave AI in Respiratory Diseases Product Offered
Table 103. PneumoWave AI in Respiratory Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. PneumoWave Main Business
Table 105. PneumoWave Latest Developments
Table 106. Respiray Details, Company Type, AI in Respiratory Diseases Area Served and Its Competitors
Table 107. Respiray AI in Respiratory Diseases Product Offered
Table 108. Respiray AI in Respiratory Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Respiray Main Business
Table 110. Respiray Latest Developments
Table 111. Dectrocel Healthcare Details, Company Type, AI in Respiratory Diseases Area Served and Its Competitors
Table 112. Dectrocel Healthcare AI in Respiratory Diseases Product Offered
Table 113. Dectrocel Healthcare AI in Respiratory Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Dectrocel Healthcare Main Business
Table 115. Dectrocel Healthcare Latest Developments
Table 116. Zynnon Details, Company Type, AI in Respiratory Diseases Area Served and Its Competitors
Table 117. Zynnon AI in Respiratory Diseases Product Offered
Table 118. Zynnon AI in Respiratory Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. Zynnon Main Business
Table 120. Zynnon Latest Developments
LIST OF FIGURES
Figure 1. AI in Respiratory Diseases Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global AI in Respiratory Diseases Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. AI in Respiratory Diseases Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. AI in Respiratory Diseases Sales Market Share by Country/Region (2025)
Figure 8. AI in Respiratory Diseases Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global AI in Respiratory Diseases Market Size Market Share by Type in 2025
Figure 10. AI in Respiratory Diseases in Hospital
Figure 11. Global AI in Respiratory Diseases Market: Hospital (2021-2026) & ($ millions)
Figure 12. AI in Respiratory Diseases in Diagnostic Centers
Figure 13. Global AI in Respiratory Diseases Market: Diagnostic Centers (2021-2026) & ($ millions)
Figure 14. AI in Respiratory Diseases in Ambulatory Surgical Centers
Figure 15. Global AI in Respiratory Diseases Market: Ambulatory Surgical Centers (2021-2026) & ($ millions)
Figure 16. AI in Respiratory Diseases in Others
Figure 17. Global AI in Respiratory Diseases Market: Others (2021-2026) & ($ millions)
Figure 18. Global AI in Respiratory Diseases Market Size Market Share by Application in 2025
Figure 19. Global AI in Respiratory Diseases Revenue Market Share by Player in 2025
Figure 20. Global AI in Respiratory Diseases Market Size Market Share by Region (2021-2026)
Figure 21. Americas AI in Respiratory Diseases Market Size 2021-2026 ($ millions)
Figure 22. APAC AI in Respiratory Diseases Market Size 2021-2026 ($ millions)
Figure 23. Europe AI in Respiratory Diseases Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa AI in Respiratory Diseases Market Size 2021-2026 ($ millions)
Figure 25. Americas AI in Respiratory Diseases Value Market Share by Country in 2025
Figure 26. United States AI in Respiratory Diseases Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada AI in Respiratory Diseases Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico AI in Respiratory Diseases Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil AI in Respiratory Diseases Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC AI in Respiratory Diseases Market Size Market Share by Region in 2025
Figure 31. APAC AI in Respiratory Diseases Market Size Market Share by Type (2021-2026)
Figure 32. APAC AI in Respiratory Diseases Market Size Market Share by Application (2021-2026)
Figure 33. China AI in Respiratory Diseases Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan AI in Respiratory Diseases Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea AI in Respiratory Diseases Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia AI in Respiratory Diseases Market Size Growth 2021-2026 ($ millions)
Figure 37. India AI in Respiratory Diseases Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia AI in Respiratory Diseases Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe AI in Respiratory Diseases Market Size Market Share by Country in 2025
Figure 40. Europe AI in Respiratory Diseases Market Size Market Share by Type (2021-2026)
Figure 41. Europe AI in Respiratory Diseases Market Size Market Share by Application (2021-2026)
Figure 42. Germany AI in Respiratory Diseases Market Size Growth 2021-2026 ($ millions)
Figure 43. France AI in Respiratory Diseases Market Size Growth 2021-2026 ($ millions)
Figure 44. UK AI in Respiratory Diseases Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy AI in Respiratory Diseases Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia AI in Respiratory Diseases Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa AI in Respiratory Diseases Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa AI in Respiratory Diseases Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa AI in Respiratory Diseases Market Size Market Share by Application (2021-2026)
Figure 50. Egypt AI in Respiratory Diseases Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa AI in Respiratory Diseases Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel AI in Respiratory Diseases Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey AI in Respiratory Diseases Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries AI in Respiratory Diseases Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 56. APAC AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 57. Europe AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 59. United States AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 60. Canada AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 61. Mexico AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 62. Brazil AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 63. China AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 64. Japan AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 65. Korea AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 67. India AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 68. Australia AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 69. Germany AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 70. France AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 71. UK AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 72. Italy AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 73. Russia AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 74. Egypt AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 75. South Africa AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 76. Israel AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 77. Turkey AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 78. Global AI in Respiratory Diseases Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global AI in Respiratory Diseases Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 1. AI in Respiratory Diseases Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global AI in Respiratory Diseases Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. AI in Respiratory Diseases Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. AI in Respiratory Diseases Sales Market Share by Country/Region (2025)
Figure 8. AI in Respiratory Diseases Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global AI in Respiratory Diseases Market Size Market Share by Type in 2025
Figure 10. AI in Respiratory Diseases in Hospital
Figure 11. Global AI in Respiratory Diseases Market: Hospital (2021-2026) & ($ millions)
Figure 12. AI in Respiratory Diseases in Diagnostic Centers
Figure 13. Global AI in Respiratory Diseases Market: Diagnostic Centers (2021-2026) & ($ millions)
Figure 14. AI in Respiratory Diseases in Ambulatory Surgical Centers
Figure 15. Global AI in Respiratory Diseases Market: Ambulatory Surgical Centers (2021-2026) & ($ millions)
Figure 16. AI in Respiratory Diseases in Others
Figure 17. Global AI in Respiratory Diseases Market: Others (2021-2026) & ($ millions)
Figure 18. Global AI in Respiratory Diseases Market Size Market Share by Application in 2025
Figure 19. Global AI in Respiratory Diseases Revenue Market Share by Player in 2025
Figure 20. Global AI in Respiratory Diseases Market Size Market Share by Region (2021-2026)
Figure 21. Americas AI in Respiratory Diseases Market Size 2021-2026 ($ millions)
Figure 22. APAC AI in Respiratory Diseases Market Size 2021-2026 ($ millions)
Figure 23. Europe AI in Respiratory Diseases Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa AI in Respiratory Diseases Market Size 2021-2026 ($ millions)
Figure 25. Americas AI in Respiratory Diseases Value Market Share by Country in 2025
Figure 26. United States AI in Respiratory Diseases Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada AI in Respiratory Diseases Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico AI in Respiratory Diseases Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil AI in Respiratory Diseases Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC AI in Respiratory Diseases Market Size Market Share by Region in 2025
Figure 31. APAC AI in Respiratory Diseases Market Size Market Share by Type (2021-2026)
Figure 32. APAC AI in Respiratory Diseases Market Size Market Share by Application (2021-2026)
Figure 33. China AI in Respiratory Diseases Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan AI in Respiratory Diseases Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea AI in Respiratory Diseases Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia AI in Respiratory Diseases Market Size Growth 2021-2026 ($ millions)
Figure 37. India AI in Respiratory Diseases Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia AI in Respiratory Diseases Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe AI in Respiratory Diseases Market Size Market Share by Country in 2025
Figure 40. Europe AI in Respiratory Diseases Market Size Market Share by Type (2021-2026)
Figure 41. Europe AI in Respiratory Diseases Market Size Market Share by Application (2021-2026)
Figure 42. Germany AI in Respiratory Diseases Market Size Growth 2021-2026 ($ millions)
Figure 43. France AI in Respiratory Diseases Market Size Growth 2021-2026 ($ millions)
Figure 44. UK AI in Respiratory Diseases Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy AI in Respiratory Diseases Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia AI in Respiratory Diseases Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa AI in Respiratory Diseases Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa AI in Respiratory Diseases Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa AI in Respiratory Diseases Market Size Market Share by Application (2021-2026)
Figure 50. Egypt AI in Respiratory Diseases Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa AI in Respiratory Diseases Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel AI in Respiratory Diseases Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey AI in Respiratory Diseases Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries AI in Respiratory Diseases Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 56. APAC AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 57. Europe AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 59. United States AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 60. Canada AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 61. Mexico AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 62. Brazil AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 63. China AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 64. Japan AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 65. Korea AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 67. India AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 68. Australia AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 69. Germany AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 70. France AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 71. UK AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 72. Italy AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 73. Russia AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 74. Egypt AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 75. South Africa AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 76. Israel AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 77. Turkey AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
Figure 78. Global AI in Respiratory Diseases Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global AI in Respiratory Diseases Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries AI in Respiratory Diseases Market Size 2027-2032 ($ millions)
